{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:17:05Z","timestamp":1776395825150,"version":"3.51.2"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.vaccine.2020.11.070","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T17:47:21Z","timestamp":1608227241000},"page":"596-604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Efficacy of an inactivated bivalent vaccine for enterovirus 71 and coxsackievirus A16 in mice immunized intradermally"],"prefix":"10.1016","volume":"39","author":[{"given":"Shengtao","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guorun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lichun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qihan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.11.070_b0005","doi-asserted-by":"crossref","DOI":"10.3201\/eid2403.171303","article-title":"Epidemiology of recurrent hand, foot and mouth disease, china, 2008\u20132015","volume":"24","author":"Huang","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2020.11.070_b0010","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1097\/INF.0000000000001242","article-title":"The epidemiology of hand, foot and mouth disease in asia: A systematic review and analysis","volume":"35","author":"Koh","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.11.070_b0015","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1743-422X-7-94","article-title":"An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in fuyang city of china","volume":"7","author":"Zhang","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2020.11.070_b0020","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S1473-3099(17)30471-1","article-title":"Hand, foot, and mouth disease in mainland china before it was listed as category c disease in May, 2008","volume":"17","author":"Li","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.11.070_b0025","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00430-016-0465-y","article-title":"Hand, foot and mouth disease (hfmd): Emerging epidemiology and the need for a vaccine strategy","volume":"205","author":"Aswathyraj","year":"2016","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2020.11.070_b0030","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated enterovirus 71 vaccine in healthy children","volume":"370","author":"Li","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.11.070_b0035","doi-asserted-by":"crossref","first-page":"e0203792","DOI":"10.1371\/journal.pone.0203792","article-title":"Population based hospitalization burden of laboratory-confirmed hand, foot and mouth disease caused by multiple enterovirus serotypes in southern china","volume":"13","author":"Yu","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.11.070_b0040","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.1016\/j.vaccine.2015.09.047","article-title":"Similar protective immunity induced by an inactivated enterovirus 71 (ev71) vaccine in neonatal rhesus macaques and children","volume":"33","author":"Zhang","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.070_b0045","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.virol.2016.10.031","article-title":"Pathologic and immunologic characteristics of coxsackievirus a16 infection in rhesus macaques","volume":"500","author":"Wang","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.11.070_b0050","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1016\/j.vaccine.2014.06.062","article-title":"Coxsackievirus a 16 infection does not interfere with the specific immune response induced by an enterovirus 71 inactivated vaccine in rhesus monkeys","volume":"32","author":"Wang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.070_b0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.virusres.2016.11.024","article-title":"Comparison analysis of micrornas in response to ev71 and ca16 infection in human bronchial epithelial cells by high-throughput sequencing to reveal differential infective mechanisms","volume":"228","author":"Hu","year":"2017","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2020.11.070_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2016.01.002","article-title":"Global gene expression analysis of peripheral blood mononuclear cells in rhesus monkey infants with ca16 infection-induced hfmd","volume":"214","author":"Song","year":"2016","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2020.11.070_b0065","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2014.03.012","article-title":"A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus a16 elicits balanced protective immunity against both viruses","volume":"32","author":"Cai","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.070_b0070","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1016\/j.vaccine.2014.06.025","article-title":"A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus a16 infections in mice","volume":"32","author":"Ku","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.070_b0075","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.4161\/hv.29823","article-title":"Evaluation of monovalent and bivalent vaccines against lethal enterovirus 71 and coxsackievirus a16 infection in newborn mice","volume":"10","author":"Sun","year":"2014","journal-title":"Hum Vacc Immunotherapeut"},{"key":"10.1016\/j.vaccine.2020.11.070_b0080","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41426-018-0094-1","article-title":"A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity","volume":"7","author":"Zhang","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2020.11.070_b0085","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.4049\/jimmunol.0901695","article-title":"Langerhans cells prime il-17-producing t cells and dampen genital cytotoxic responses following mucosal immunization","volume":"184","author":"Hervouet","year":"2010","journal-title":"J Immunol"},{"issue":"1387\u20131397","key":"10.1016\/j.vaccine.2020.11.070_b0090","first-page":"e1381","article-title":"Skin dendritic cells induce follicular helper t cells and protective humoral immune responses","volume":"136","author":"Yao","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2020.11.070_b0095","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri2622","article-title":"Skin immune sentinels in health and disease","volume":"9","author":"Nestle","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2020.11.070_b0100","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3389\/fimmu.2018.01768","article-title":"Uncovering the mysteries of langerhans cells, inflammatory dendritic epidermal cells, and monocyte-derived langerhans cell-like cells in the epidermis","volume":"9","author":"Otsuka","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2020.11.070_b0105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0171-2985(84)80117-5","article-title":"Langerhans cells: Antigen presenting cells of the epidermis","volume":"168","author":"Streilein","year":"1984","journal-title":"Immunobiology"},{"key":"10.1016\/j.vaccine.2020.11.070_b0110","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.vaccine.2013.09.074","article-title":"Immunogenicity and safety of fluzone((r)) intradermal and high-dose influenza vaccines in older adults >\/=65 years of age: A randomized, controlled, phase ii trial","volume":"32","author":"Tsang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.070_b0115","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1016\/j.vaccine.2010.06.062","article-title":"Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults","volume":"28","author":"Laurent","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.070_b0120","doi-asserted-by":"crossref","first-page":"10383","DOI":"10.3748\/wjg.v20.i30.10383","article-title":"Hepatitis b vaccine by intradermal route in non responder patients: An update","volume":"20","author":"Filippelli","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vaccine.2020.11.070_b0125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41541-019-0108-6","article-title":"Role of innate lymphoid cells and dendritic cells in intradermal immunization of the enterovirus antigen","volume":"4","author":"Fan","year":"2019","journal-title":"npj Vacc"},{"key":"10.1016\/j.vaccine.2020.11.070_b0130","first-page":"481","article-title":"Collaborative study on calibration and applicability of national antigen standard for coxsackievirus a16 vaccine","volume":"8","author":"Mao","year":"2018","journal-title":"Chin J Viral Dis"},{"key":"10.1016\/j.vaccine.2020.11.070_b0135","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1146\/annurev-immunol-051116-052215","article-title":"Antigen-presenting cells in the skin","volume":"35","author":"Kashem","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2020.11.070_b0140","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nri3683","article-title":"The origins and functions of dendritic cells and macrophages in the skin","volume":"14","author":"Malissen","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2020.11.070_b0145","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1016\/j.vaccine.2009.05.066","article-title":"Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: A randomized controlled trial","volume":"27","author":"Chiu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.070_b0150","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1542\/peds.2006-3176","article-title":"Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children","volume":"119","author":"Chiu","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2020.11.070_b0155","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.vaccine.2011.12.069","article-title":"Quantitative and qualitative analysis of antibody response after dose sparing intradermal 2009 h1n1 vaccination","volume":"30","author":"Hung","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.070_b0160","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.vaccine.2008.10.077","article-title":"Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults","volume":"27","author":"Van Damme","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.070_b0165","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.1016\/j.vaccine.2012.08.014","article-title":"Dose sparing intradermal trivalent influenza (2010\/2011) vaccination overcomes reduced immunogenicity of the 2009 h1n1 strain","volume":"30","author":"Hung","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.070_b0170","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1016\/j.vaccine.2008.09.078","article-title":"Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults","volume":"26","author":"Leroux-Roels","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.070_b0175","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ni.3484","article-title":"Innate lymphoid cell function in the context of adaptive immunity","volume":"17","author":"Bando","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2020.11.070_b0180","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/jid.2014.401","article-title":"Innate lymphoid cells in the skin","volume":"135","author":"Kim","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.vaccine.2020.11.070_b0185","doi-asserted-by":"crossref","first-page":"aaa6566","DOI":"10.1126\/science.aaa6566","article-title":"Innate lymphoid cells. Innate lymphoid cells: A new paradigm in immunology","volume":"348","author":"Eberl","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2020.11.070_b0195","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/s41590-019-0430-1","article-title":"Mouse cytomegalovirus-experienced ilc1s acquire a memory response dependent on the viral glycoprotein m12","volume":"20","author":"Weizman","year":"2019","journal-title":"Nat Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20315528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20315528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:52:59Z","timestamp":1759402379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20315528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0264410X20315528"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.070","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of an inactivated bivalent vaccine for enterovirus 71 and coxsackievirus A16 in mice immunized intradermally","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}